English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 24, 2026

BIO CEO Crowley and DOD doctor Overton considered top candidates for FDA commissioner
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Review finds limited evidence that yo-yo dieting causes lasting health harm
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

AbbVie acquires Apogee Therapeutics as biopharma M&A activity continues in 2026
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

REGENXBIO plans accelerated approval filing for Duchenne gene therapy amid FDA policy shifts
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Mesh-free hernia repair provides new surgical option at Northwestern Medicine
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Study finds red meat may worsen inflammatory bowel disease, pea protein shows milder effects
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Serapha Bio announces reverse merger with Boundless Bio and $230 million funding round
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Researchers find genetic links between air pollution and severe asthma symptoms

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation